Press Releases from Exactitude Consultancy (20114 total)
Pegcetacoplan is approved by the FDA for patients aged 12 and up with rare kidne …
The global Rare Kidney Diseases Market is gaining significant attention as nephrology research, personalized medicine, and orphan drug development continue to expand. Rare kidney diseases…
NRAS, HRAS, and KRAS Market Targeting Key Oncogenes in the Era of Precision Medi …
Introduction
The RAS gene family - comprising NRAS, HRAS, and KRAS - plays a pivotal role in regulating cell proliferation, differentiation, and survival. Mutations in these…
Current study on mesenchymal stem cell exosome therapy's potential to reverse no …
The global Exosome Therapy Market is emerging as a transformative frontier in regenerative medicine, precision diagnostics, and targeted drug delivery. Exosomes, nanosized extracellular vesicles secreted…
A 'Silver Lining' for Ascending Thoracic Aortic Aneurysms
Introduction
A thoracic aortic aneurysm (TAA) is a serious cardiovascular condition characterized by abnormal dilation of the aorta within the chest, which can lead to life-threatening…
For the targeted treatment of localized prostate cancer, photodynamic therapy
Introduction
Photodynamic therapy (PDT) is an innovative, minimally invasive treatment that combines photosensitizing agents, oxygen, and light to selectively destroy abnormal or cancerous cells. Originally developed…
From mechanism of action to prospective immunotherapeutic methods, TIGIT in canc …
Introduction
The field of immuno-oncology has revolutionized cancer treatment, with checkpoint inhibitors such as PD-1, PD-L1, and CTLA-4 therapies transforming outcomes for patients with advanced malignancies.…
Epstein-Barr Is Riskier Than You May Imagine
Introduction
The Epstein-Barr virus (EBV), a member of the herpesvirus family, is one of the most common human viruses, infecting nearly 90-95 % of the global…
Plexiform Neurofibroma Market to Reach USD 1.1 Billion by 2034, Growing at 10.7% …
Introduction
Plexiform neurofibroma (PN) is a rare, benign but potentially disfiguring and debilitating tumor associated with neurofibromatosis type 1 (NF1), a genetic disorder caused by mutations…
Angiomatosis Market to Reach USD 740 Million by 2034, Growing at 9.2% CAGR
Introduction
Angiomatosis is a rare, benign condition characterized by the proliferation of blood vessels, often presenting as diffuse vascular lesions that can affect skin, soft tissues,…
C3 Glomerulopathy Market Emerging Therapeutics for a Rare Kidney Disorder
Introduction
C3 glomerulopathy (C3G) is a rare, progressive kidney disease characterized by abnormal complement system activation, leading to deposition of complement protein C3 in the glomeruli.…
DNA and Gene Cloning Services Market Driving Breakthroughs in Genomics, Therapeu …
The global DNA and Gene Cloning Services Market is becoming a cornerstone of modern biotechnology and life sciences research. Gene cloning services, which involve replicating…
Bioassay Services Market to Reach USD 7.4 Billion by 2034, Growing at 10.1% CAGR
Introduction
Bioassays are critical tools in life sciences, enabling researchers to measure the effects of drugs, chemicals, and biological agents on living systems. They serve as…
Metal and Lipid nanoparticles, such as liposomes and LNPs, are continuously proc …
Introduction
Nanoparticles have transformed modern medicine and biotechnology, offering precise, targeted, and efficient delivery mechanisms for therapeutics, vaccines, and diagnostics. Among them, metal nanoparticles (such as…
Spatial Genomics and Transcriptomics Market to Hit USD 2.8 Billion by 2034
The global Spatial Genomics and Transcriptomics Market is reshaping the way researchers understand complex biological systems. Unlike traditional genomic and transcriptomic methods that average signals…
Esperovax Receives Subcontract for Thermostable Oral Vaccine Platform Developmen …
Introduction
Vaccines are among the most effective tools in modern medicine, preventing millions of deaths annually. However, one of the persistent challenges in global immunization programs…
A combination of anti-aging drug increases the lifetime of mice by 30% and gives …
The global Anti-Aging Drugs Market is entering a dynamic growth phase, fueled by advances in regenerative medicine, biotechnology, and preventive healthcare. As populations age worldwide,…
FDA decision on relacorilant for Cushing's expected by year's end
Introduction
Cushing's syndrome is a rare but serious endocrine disorder caused by prolonged exposure to high cortisol levels. It can occur due to long-term use of…
RNA Extraction and Purification Market to Reach USD 5.4 Billion by 2034
The global RNA Extraction and RNA Purification Market is a critical segment of the molecular biology and life sciences ecosystem, enabling breakthroughs in genomics, diagnostics,…
Advances in the Study of Macular Degeneration Addressing the Rising Global Burde …
Introduction
Macular degeneration, particularly age-related macular degeneration (AMD), is one of the leading causes of irreversible vision loss among adults over 50. It affects the macula…
Baby healed in world's first gene-editing therapy; Indian-origin doctor plays ke …
Introduction
Genome editing has transitioned from a theoretical possibility to a transformative therapeutic reality. With tools such as CRISPR-Cas9, TALENs, and zinc finger nucleases (ZFNs), scientists…
A New Study Verifies Insulin Nasal Spray's Ability to Deliver Alzheimer's Drug S …
Introduction
Drug delivery innovation has been a driving force in enhancing patient outcomes, improving compliance, and maximizing therapeutic efficiency. Among non-invasive routes, nasal drug delivery has…
RION Works with Lonza to Expand the Production and Development of Exosomes
The global Exosomes Development and Manufacturing Market is emerging as a critical enabler of regenerative medicine, oncology, neurology, and advanced drug delivery systems. Exosomes-nanosized extracellular…
A Novel Approach to Molecular Cancer Imaging Technologies: Aptamers
The global Aptamers Market is gaining strong momentum as biotechnology and pharmaceutical companies increasingly leverage aptamers for drug discovery, diagnostics, targeted therapeutics, and biomarker research.…
Thermo Fisher Scientific Launches New Spectral Flow Cytometer Offering Increased …
Introduction
Flow cytometry has become a cornerstone technology in modern biomedical research and clinical diagnostics. By enabling rapid, quantitative, and multiparametric analysis of single cells in…
BlackRock removes plant-based meat from its nutrition fund
The global Plant-Based Meats Market is undergoing a transformative phase, driven by shifting consumer preferences, environmental concerns, and advancements in food technology. Plant-based meats are…
The first patient clinical study for a Therapeutic vaccine against chronic hepat …
The global Therapeutic Vaccines Market is witnessing strong momentum as healthcare moves beyond preventive immunization toward disease-modifying and curative solutions. Unlike traditional vaccines that prevent…
Elegen and Integrated DNA Technologies collaborate to transform the market for l …
The global DNA Synthesis Market is rapidly becoming the backbone of modern biotechnology, genomics, and personalized medicine. DNA synthesis-the artificial creation of DNA sequences-has evolved…
A Potential Synthetic Vaccine Adjuvant for Tuberculosis Vaccines
Introduction
Protein expression systems are the foundation of modern biotechnology, enabling the production of therapeutic proteins, enzymes, and vaccines. While bacterial, yeast, and mammalian cell expression…
Analysis of the Clinical Trial Pipeline for Complement Inhibitors: 40+ Important …
The global Complement Inhibitors Market is gaining strong momentum as biotechnology and pharmaceutical industries focus on therapies targeting the complement system-an integral part of the…
CAR-T Cell Therapies Market : White Space Opportunities in Next-Generation
Introduction
Chimeric Antigen Receptor T-cell (CAR-T) therapy is revolutionizing cancer treatment by enabling a patient's immune system to identify and destroy malignant cells with unprecedented precision.…
Information about immune checkpoint inhibitors for colorectal cancer is revealed …
The global Immune Checkpoint Inhibitors Clinical Trials Analysis Market is expanding rapidly as oncology research increasingly focuses on immunotherapy as a frontline treatment for cancer.…
A new Myeloid Cell Targeting Therapeutics participant joins the clinic | ApexOnc …
The global Myeloid Cell Targeting Therapeutics Market is gaining significant traction as immuno-oncology research increasingly recognizes the role of myeloid cells in cancer progression, immune…
Cell and Gene Therapy Market : Transforming the Future of Medicine
Introduction
Cell and gene therapies (CGT) represent one of the most revolutionary shifts in modern healthcare, offering the potential to cure diseases at their genetic and…
ADC Cytotoxic Payloads and Warheads Driving the Next Wave of Targeted Cancer The …
The global Antibody-Drug Conjugate (ADC) Cytotoxic Payloads and Warheads Market is expanding rapidly as ADCs emerge as a cornerstone of targeted cancer therapy. ADCs combine…
Molecular Cloning Market Enabling Breakthroughs in Biotechnology and Drug Discov …
Introduction
Molecular cloning has become a cornerstone of modern biotechnology and life sciences, empowering researchers to isolate, manipulate, and replicate specific DNA sequences. It is a…
VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy Has Been A …
The global Demyelinating Polyneuropathy Market is witnessing rapid growth, driven by rising prevalence of autoimmune and neuromuscular disorders, advances in diagnostics, and the introduction of…
A Potential Synthetic Vaccine Adjuvant for Tuberculosis Vaccines
Vaccination is one of the most impactful public health interventions of modern times, saving millions of lives annually. However, not all vaccines are equally effective…
Guidelines for clinical practice in the identification and treatment of X-Linked …
The global X-Linked Hypophosphatemia (XLH) Market is emerging as an important segment within the rare disease therapeutics landscape. XLH is a rare genetic disorder characterized…
Recent studies provide insight into the genetic causes of amblyopia
The global Amblyopia Market is expanding steadily as awareness, screening, and treatment options for this common childhood vision disorder improve worldwide. Amblyopia, also known as…
The US FDA Gives Shanton Fast Track Status in the Refractory Gout Program
The global Refractory Gout Market is gaining attention as a critical area in rheumatology, reflecting the need for effective therapies to treat patients who do…
Changing Methods for Taste Masking: Enhancing Patient Compliance and Product Inn …
Introduction
The pharmaceutical and nutraceutical industries are witnessing a growing demand for solutions that improve the palatability of drugs and supplements. For patients, especially children, the…
Neutra Corp. will establish a new clinical research site management organization …
The global Site Management Organization (SMO) Market is becoming increasingly vital in the clinical research ecosystem, supporting pharmaceutical, biotechnology, and medical device companies in conducting…
Tr1 Treg Treatment to Be Assessed in a Crohn's Disease Trial
The global Treg Therapy Market is rapidly gaining momentum as regulatory T-cell (Treg) therapies emerge as a transformative approach in immunology. Tregs are a specialized…
Oral Oncolytics Leukemia Market to Reach USD 24.7 Billion by 2034, Growing at 9. …
Introduction
Leukemia remains one of the most challenging hematological malignancies, with millions of patients worldwide requiring lifelong monitoring and treatment. Traditionally, chemotherapy and injectable biologics dominated…
Tissue Engineering Market to Reach USD 56.68 Billion Globally by 2035 at 10.1% C …
Introduction
Tissue engineering stands at the vanguard of regenerative medicine - a domain in which engineered scaffolds, stem cells, biomaterials, and advanced technologies converge to repair…
Viral Vector Manufacturing Market to Surge to USD 43.04 Billion by 2034, Growing …
Introduction
The healthcare industry is entering a transformative era where precision therapies are reshaping how we treat diseases. Among the most groundbreaking innovations, viral vectors have…
Veterinary Vaccines Market to Reach USD 20.65 Billion by 2034, Growing at 6.4% C …
Introduction
Animal health is a cornerstone of global food security, sustainable agriculture, and public health. With rising concerns over zoonotic diseases, antimicrobial resistance, and livestock productivity,…
Intravenous Immunoglobulin (IVIG) Market to Reach USD 27.1 Billion by 2034, Grow …
Introduction
In recent years, the healthcare industry has seen significant progress in therapies targeting immune system disorders and rare diseases. At the forefront of these therapies…
Lipid Nanoparticle Manufacturing Market to Reach USD 2.48 Billion by 2034, Growi …
Introduction
The pharmaceutical and biotechnology industries are undergoing a paradigm shift driven by the success of mRNA vaccines and the growing promise of gene therapies. At…
Next-Generation Drug Conjugates Market to Reach USD 16.5 Billion by 2034, Growin …
Introduction
In the rapidly evolving pharmaceutical landscape, precision medicine has become the cornerstone of innovation. Among the most promising therapeutic approaches, next-generation drug conjugates (NGDCs) are…
Go To Page: 21 22 23 24 25 26 27 28 29 30 231 232 233 234 235 236 237 238 239 240
